Chemotherapy in lung cancer.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Postgraduate medical journal

• Publication date

  1989-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/pgmj.65.763.291PMID 2558370PMCID PMC2429318
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• First-line chemotherapy rechallenge after relapse in small cell lung cancer

  2004cited by this paper
• High-dose cyclophosphamide with autologous marrow transplantation for small cell carcinoma of the bronchus

  2004cited by this paper
• A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.

  1989cited by this paper
• [The role of radiotherapy in small cell lung cancer].

  1988cited by this paper
• Quality-of-life of cancer patients.

  1988cited by this paper
• Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare.

  1988cited by this paper
• Alternating versus sequential chemotherapy in small cell lung cancer. A randomized german multicenter trial

  1987cited by this paper
• Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer.

  1987cited by this paper
• A randomized trial comparing vindesine and cisplatinum to vindesine and methotrexate in advanced non small cell lung carcinoma.

  1987cited by this paper
• Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada.

  1987cited by this paper
• Long-term survival in small cell carcinoma of the lung.

  1987cited by this paper
• Quality of life in patients with non-small cell lung cancer treated with chemotherapy.

  1987cited by this paper
• Vincristine and etoposide: an effective chemotherapy regimen with reduced toxicity in extensive small-cell lung cancer.

  1987cited by this paper
• Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.

  1987cited by this paper
• Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional staging.

  1987cited by this paper
• Tumor markers in small cell lung cancer.

  1987cited by this paper
• Small cell carcinoma of the lung: influence of age on treatment outcome.

  1987cited by this paper
• Long-term survival in small cell carcinoma of the lung.

  1987cited by this paper
• Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung.

  1987cited by this paper
• Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases.

  1986cited by this paper
• Rationale for chemotherapy for patients with advanced non-small-cell lung cancer.

  1986cited by this paper
• Short duration combination chemotherapy in the treatment of small cell lung cancer.

  1986cited by this paper
• Combined chemotherapy and radiation therapy for non-small-cell lung cancer.

  1986cited by this paper
• Rationale for chemotherapy for patients with advanced non-small-cell lung cancer.

  1986cited by this paper
• Vindesine, cisplatin, and bleomycin combination chemotherapy in non-small cell lung cancer: survival and quality of life.

  1986cited by this paper
• Neurologic, neuropsychologic, and computed cranial tomography scan abnormalities in 2- to 10-year survivors of small-cell lung cancer.

  1985cited by this paper
• Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung.

  1985cited by this paper
• Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-up.

  1985cited by this paper
• VP-16 and cisplatin in the treatment of non-small-cell lung cancer.

  1985cited by this paper
• Intensive chemotherapy with autologous bone marrow transplantation in small cell carcinoma of the lung.

  1985cited by this paper
• Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer.

  1985cited by this paper
• Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer.

  1985cited by this paper
• Long-term survivors of small cell carcinoma of the lung.

  1985cited by this paper
• Patterns of failure in small cell lung cancer: implications for therapy.

  1984cited by this paper
• Long-term survival and toxicity in small cell lung cancer. Southwest Oncology Group study.

  1984cited by this paper
• Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial.

  1984cited by this paper
• Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung.

  1984cited by this paper
• Intensive chemoradiotherapy with autologous marrow transplantation for small cell carcinoma of the lung.

  1983cited by this paper
• Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantation.

  1983cited by this paper
• Etoposide (VP-16) in the treatment of lung cancer.

  1983cited by this paper
• Rationale for the use of alternating non-cross-resistant chemotherapy.

  1982cited by this paper
• Experimental combination and single-agent chemotherapy in human lung-tumour xenografts.

  1982cited by this paper
• Prognostic factors in small cell carcinoma of the lung: a cancer and leukemia group B study.

  1981cited by this paper
• Small Cell Bronchogenic Carcinoma: A Review of Therapeutic Results

  1981cited by this paper
• Prognostic factors in small cell carcinoma of the lung: a cancer and leukemia group B study.

  1981cited by this paper
• An analysis of the reporting of results in lung cancer drug trials.

  1980cited by this paper
• A randomized study: small cell anaplastic lung cancer treated by combination chemotherapy and adjuvant radiotherapy.

  1980cited by this paper
• Prognostic factors for survival in patients with inoperable lung cancer.

  1980cited by this paper
• CNS metastases in small cell bronchogenic carcinoma. Increasing frequency and changing pattern with lengthening survival

  1979cited by this paper
• Central nervous system metastases in small cell bronchogenic carcinoma.

  1978cited by this paper
• Long‐term Survival After Resection for Bronchogenic Carcinoma

  1976cited by this paper
• Intermittent high-dose cyclophosphamide (NSC-26271) treatment of stage III ovarian carcinoma.

  1974cited by this paper
• Keynote address on biostatistics and data retrieval.

  1973cited by this paper
• The quality of life.

  1970cited by this paper
• Alkylating agents in bronchogenic carcinoma.

  1969cited by this paper

• Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen.

  2005cites this paper
• Novas drogas no tratamento do carcinoma do pulmão não pequenas células

  2000cites this paper
• Respiratory disease in old age. Part 1: age-related changes in the lung, respiratory infections and lung tumours

  1993cites this paper
• Combination cytotoxic effects of cis-diamminedichloroplatinum(II) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines.

  1993cites this paper
• O6-methylguanine-DNA methyltransferase in human normal and malignant lung tissues.

  1993cites this paper
• Ifosfamide/carboplatin/etoposide (ICE) regimen in small cell lung cancer

  1993cites this paper
• Ki‐67 immunostaining and survival in operable lung cancer

  1991cites this paper